Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Research Report 2024

Report ID: 1994261 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Oral
        1.2.3 Intravenous Injection
        1.2.4 Intramuscular Injection
    1.3 Market by Application
        1.3.1 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Perspective (2017-2028)
    2.2 Acute Respiratory Distress Syndrome (ARDS) Treatment Growth Trends by Region
        2.2.1 Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Acute Respiratory Distress Syndrome (ARDS) Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Acute Respiratory Distress Syndrome (ARDS) Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Acute Respiratory Distress Syndrome (ARDS) Treatment Market Dynamics
        2.3.1 Acute Respiratory Distress Syndrome (ARDS) Treatment Industry Trends
        2.3.2 Acute Respiratory Distress Syndrome (ARDS) Treatment Market Drivers
        2.3.3 Acute Respiratory Distress Syndrome (ARDS) Treatment Market Challenges
        2.3.4 Acute Respiratory Distress Syndrome (ARDS) Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Acute Respiratory Distress Syndrome (ARDS) Treatment Players by Revenue
        3.1.1 Global Top Acute Respiratory Distress Syndrome (ARDS) Treatment Players by Revenue (2017-2022)
        3.1.2 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue
    3.4 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Concentration Ratio
        3.4.1 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in 2021
    3.5 Acute Respiratory Distress Syndrome (ARDS) Treatment Key Players Head office and Area Served
    3.6 Key Players Acute Respiratory Distress Syndrome (ARDS) Treatment Product Solution and Service
    3.7 Date of Enter into Acute Respiratory Distress Syndrome (ARDS) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Respiratory Distress Syndrome (ARDS) Treatment Breakdown Data by Type
    4.1 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Forecasted Market Size by Type (2023-2028)
5 Acute Respiratory Distress Syndrome (ARDS) Treatment Breakdown Data by Application
    5.1 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Acute Respiratory Distress Syndrome (ARDS) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size (2017-2028)
    6.2 North America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2017-2022)
    6.3 North America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size (2017-2028)
    7.2 Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2017-2022)
    7.3 Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size (2017-2028)
    9.2 Latin America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2017-2022)
    9.3 Latin America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Gilead Sciences Inc.
        11.1.1 Gilead Sciences Inc. Company Detail
        11.1.2 Gilead Sciences Inc. Business Overview
        11.1.3 Gilead Sciences Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.1.4 Gilead Sciences Inc. Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.1.5 Gilead Sciences Inc. Recent Development
    11.2 Terumo Corporation
        11.2.1 Terumo Corporation Company Detail
        11.2.2 Terumo Corporation Business Overview
        11.2.3 Terumo Corporation Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.2.4 Terumo Corporation Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.2.5 Terumo Corporation Recent Development
    11.3 Getinge Ab
        11.3.1 Getinge Ab Company Detail
        11.3.2 Getinge Ab Business Overview
        11.3.3 Getinge Ab Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.3.4 Getinge Ab Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.3.5 Getinge Ab Recent Development
    11.4 Livanova Plc
        11.4.1 Livanova Plc Company Detail
        11.4.2 Livanova Plc Business Overview
        11.4.3 Livanova Plc Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.4.4 Livanova Plc Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.4.5 Livanova Plc Recent Development
    11.5 Medtronic
        11.5.1 Medtronic Company Detail
        11.5.2 Medtronic Business Overview
        11.5.3 Medtronic Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.5.4 Medtronic Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.5.5 Medtronic Recent Development
    11.6 Alung Technologies, Inc.
        11.6.1 Alung Technologies, Inc. Company Detail
        11.6.2 Alung Technologies, Inc. Business Overview
        11.6.3 Alung Technologies, Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.6.4 Alung Technologies, Inc. Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.6.5 Alung Technologies, Inc. Recent Development
    11.7 Armstrong Medical
        11.7.1 Armstrong Medical Company Detail
        11.7.2 Armstrong Medical Business Overview
        11.7.3 Armstrong Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.7.4 Armstrong Medical Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.7.5 Armstrong Medical Recent Development
    11.8 Besmed Health Business Corp.
        11.8.1 Besmed Health Business Corp. Company Detail
        11.8.2 Besmed Health Business Corp. Business Overview
        11.8.3 Besmed Health Business Corp. Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.8.4 Besmed Health Business Corp. Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.8.5 Besmed Health Business Corp. Recent Development
    11.9 Dragerwerk Ag & Co. Kgaa
        11.9.1 Dragerwerk Ag & Co. Kgaa Company Detail
        11.9.2 Dragerwerk Ag & Co. Kgaa Business Overview
        11.9.3 Dragerwerk Ag & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.9.4 Dragerwerk Ag & Co. Kgaa Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.9.5 Dragerwerk Ag & Co. Kgaa Recent Development
    11.10 Eurosets
        11.10.1 Eurosets Company Detail
        11.10.2 Eurosets Business Overview
        11.10.3 Eurosets Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.10.4 Eurosets Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.10.5 Eurosets Recent Development
    11.11 F. Hoffmann-la Roche Ltd.
        11.11.1 F. Hoffmann-la Roche Ltd. Company Detail
        11.11.2 F. Hoffmann-la Roche Ltd. Business Overview
        11.11.3 F. Hoffmann-la Roche Ltd. Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.11.4 F. Hoffmann-la Roche Ltd. Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.11.5 F. Hoffmann-la Roche Ltd. Recent Development
    11.12 Fisher & Paykel Healthcare Limited
        11.12.1 Fisher & Paykel Healthcare Limited Company Detail
        11.12.2 Fisher & Paykel Healthcare Limited Business Overview
        11.12.3 Fisher & Paykel Healthcare Limited Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.12.4 Fisher & Paykel Healthcare Limited Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.12.5 Fisher & Paykel Healthcare Limited Recent Development
    11.13 Fresenius Se & Co. Kgaa
        11.13.1 Fresenius Se & Co. Kgaa Company Detail
        11.13.2 Fresenius Se & Co. Kgaa Business Overview
        11.13.3 Fresenius Se & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.13.4 Fresenius Se & Co. Kgaa Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.13.5 Fresenius Se & Co. Kgaa Recent Development
    11.14 Hamilton Medical
        11.14.1 Hamilton Medical Company Detail
        11.14.2 Hamilton Medical Business Overview
        11.14.3 Hamilton Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.14.4 Hamilton Medical Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.14.5 Hamilton Medical Recent Development
    11.15 Nice Neotech Medical Systems Pvt.ltd.
        11.15.1 Nice Neotech Medical Systems Pvt.ltd. Company Detail
        11.15.2 Nice Neotech Medical Systems Pvt.ltd. Business Overview
        11.15.3 Nice Neotech Medical Systems Pvt.ltd. Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.15.4 Nice Neotech Medical Systems Pvt.ltd. Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.15.5 Nice Neotech Medical Systems Pvt.ltd. Recent Development
    11.16 Nipro
        11.16.1 Nipro Company Detail
        11.16.2 Nipro Business Overview
        11.16.3 Nipro Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.16.4 Nipro Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.16.5 Nipro Recent Development
    11.17 Pfizer Inc.
        11.17.1 Pfizer Inc. Company Detail
        11.17.2 Pfizer Inc. Business Overview
        11.17.3 Pfizer Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.17.4 Pfizer Inc. Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.17.5 Pfizer Inc. Recent Development
    11.18 Resmed
        11.18.1 Resmed Company Detail
        11.18.2 Resmed Business Overview
        11.18.3 Resmed Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.18.4 Resmed Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.18.5 Resmed Recent Development
    11.19 Smiths Medical
        11.19.1 Smiths Medical Company Detail
        11.19.2 Smiths Medical Business Overview
        11.19.3 Smiths Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.19.4 Smiths Medical Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.19.5 Smiths Medical Recent Development
    11.20 Weinmann Emergency Medical Technology Gmbh+co. Kg
        11.20.1 Weinmann Emergency Medical Technology Gmbh+co. Kg Company Detail
        11.20.2 Weinmann Emergency Medical Technology Gmbh+co. Kg Business Overview
        11.20.3 Weinmann Emergency Medical Technology Gmbh+co. Kg Acute Respiratory Distress Syndrome (ARDS) Treatment Introduction
        11.20.4 Weinmann Emergency Medical Technology Gmbh+co. Kg Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
        11.20.5 Weinmann Emergency Medical Technology Gmbh+co. Kg Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Oral
    Table 3. Key Players of Intravenous Injection
    Table 4. Key Players of Intramuscular Injection
    Table 5. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Region (2017-2022)
    Table 9. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Region (2023-2028)
    Table 11. Acute Respiratory Distress Syndrome (ARDS) Treatment Market Trends
    Table 12. Acute Respiratory Distress Syndrome (ARDS) Treatment Market Drivers
    Table 13. Acute Respiratory Distress Syndrome (ARDS) Treatment Market Challenges
    Table 14. Acute Respiratory Distress Syndrome (ARDS) Treatment Market Restraints
    Table 15. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Players (2017-2022)
    Table 17. Global Top Acute Respiratory Distress Syndrome (ARDS) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment as of 2021)
    Table 18. Ranking of Global Top Acute Respiratory Distress Syndrome (ARDS) Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Acute Respiratory Distress Syndrome (ARDS) Treatment Product Solution and Service
    Table 22. Date of Enter into Acute Respiratory Distress Syndrome (ARDS) Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share by Application (2017-2022)
    Table 30. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue Market Share by Application (2023-2028)
    Table 32. North America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Gilead Sciences Inc. Company Detail
    Table 43. Gilead Sciences Inc. Business Overview
    Table 44. Gilead Sciences Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Product
    Table 45. Gilead Sciences Inc. Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 46. Gilead Sciences Inc. Recent Development
    Table 47. Terumo Corporation Company Detail
    Table 48. Terumo Corporation Business Overview
    Table 49. Terumo Corporation Acute Respiratory Distress Syndrome (ARDS) Treatment Product
    Table 50. Terumo Corporation Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 51. Terumo Corporation Recent Development
    Table 52. Getinge Ab Company Detail
    Table 53. Getinge Ab Business Overview
    Table 54. Getinge Ab Acute Respiratory Distress Syndrome (ARDS) Treatment Product
    Table 55. Getinge Ab Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 56. Getinge Ab Recent Development
    Table 57. Livanova Plc Company Detail
    Table 58. Livanova Plc Business Overview
    Table 59. Livanova Plc Acute Respiratory Distress Syndrome (ARDS) Treatment Product
    Table 60. Livanova Plc Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 61. Livanova Plc Recent Development
    Table 62. Medtronic Company Detail
    Table 63. Medtronic Business Overview
    Table 64. Medtronic Acute Respiratory Distress Syndrome (ARDS) Treatment Product
    Table 65. Medtronic Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 66. Medtronic Recent Development
    Table 67. Alung Technologies, Inc. Company Detail
    Table 68. Alung Technologies, Inc. Business Overview
    Table 69. Alung Technologies, Inc. Acute Respiratory Distress Syndrome (ARDS) Treatment Product
    Table 70. Alung Technologies, Inc. Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 71. Alung Technologies, Inc. Recent Development
    Table 72. Armstrong Medical Company Detail
    Table 73. Armstrong Medical Business Overview
    Table 74. Armstrong Medical Acute Respiratory Distress Syndrome (ARDS) Treatment Product
    Table 75. Armstrong Medical Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 76. Armstrong Medical Recent Development
    Table 77. Besmed Health Business Corp. Company Detail
    Table 78. Besmed Health Business Corp. Business Overview
    Table 79. Besmed Health Business Corp. Acute Respiratory Distress Syndrome (ARDS) Treatment Product
    Table 80. Besmed Health Business Corp. Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 81. Besmed Health Business Corp. Recent Development
    Table 82. Dragerwerk Ag & Co. Kgaa Company Detail
    Table 83. Dragerwerk Ag & Co. Kgaa Business Overview
    Table 84. Dragerwerk Ag & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) Treatment Product
    Table 85. Dragerwerk Ag & Co. Kgaa Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 86. Dragerwerk Ag & Co. Kgaa Recent Development
    Table 87. Eurosets Company Detail
    Table 88. Eurosets Business Overview
    Table 89. Eurosets Acute Respiratory Distress Syndrome (ARDS) Treatment Product
    Table 90. Eurosets Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 91. Eurosets Recent Development
    Table 92. F. Hoffmann-la Roche Ltd. Company Detail
    Table 93. F. Hoffmann-la Roche Ltd. Business Overview
    Table 94. F. Hoffmann-la Roche Ltd. Acute Respiratory Distress Syndrome (ARDS) TreatmentProduct
    Table 95. F. Hoffmann-la Roche Ltd. Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 96. F. Hoffmann-la Roche Ltd. Recent Development
    Table 97. Fisher & Paykel Healthcare Limited Company Detail
    Table 98. Fisher & Paykel Healthcare Limited Business Overview
    Table 99. Fisher & Paykel Healthcare Limited Acute Respiratory Distress Syndrome (ARDS) TreatmentProduct
    Table 100. Fisher & Paykel Healthcare Limited Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 101. Fisher & Paykel Healthcare Limited Recent Development
    Table 102. Fresenius Se & Co. Kgaa Company Detail
    Table 103. Fresenius Se & Co. Kgaa Business Overview
    Table 104. Fresenius Se & Co. Kgaa Acute Respiratory Distress Syndrome (ARDS) TreatmentProduct
    Table 105. Fresenius Se & Co. Kgaa Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 106. Fresenius Se & Co. Kgaa Recent Development
    Table 107. Hamilton Medical Company Detail
    Table 108. Hamilton Medical Business Overview
    Table 109. Hamilton Medical Acute Respiratory Distress Syndrome (ARDS) TreatmentProduct
    Table 110. Hamilton Medical Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 111. Hamilton Medical Recent Development
    Table 112. Nice Neotech Medical Systems Pvt.ltd. Company Detail
    Table 113. Nice Neotech Medical Systems Pvt.ltd. Business Overview
    Table 114. Nice Neotech Medical Systems Pvt.ltd. Acute Respiratory Distress Syndrome (ARDS) TreatmentProduct
    Table 115. Nice Neotech Medical Systems Pvt.ltd. Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 116. Nice Neotech Medical Systems Pvt.ltd. Recent Development
    Table 117. Nipro Company Detail
    Table 118. Nipro Business Overview
    Table 119. Nipro Acute Respiratory Distress Syndrome (ARDS) TreatmentProduct
    Table 120. Nipro Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 121. Nipro Recent Development
    Table 122. Pfizer Inc. Company Detail
    Table 123. Pfizer Inc. Business Overview
    Table 124. Pfizer Inc. Acute Respiratory Distress Syndrome (ARDS) TreatmentProduct
    Table 125. Pfizer Inc. Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 126. Pfizer Inc. Recent Development
    Table 127. Resmed Company Detail
    Table 128. Resmed Business Overview
    Table 129. Resmed Acute Respiratory Distress Syndrome (ARDS) TreatmentProduct
    Table 130. Resmed Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 131. Resmed Recent Development
    Table 132. Smiths Medical Company Detail
    Table 133. Smiths Medical Business Overview
    Table 134. Smiths Medical Acute Respiratory Distress Syndrome (ARDS) TreatmentProduct
    Table 135. Smiths Medical Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 136. Smiths Medical Recent Development
    Table 137. Weinmann Emergency Medical Technology Gmbh+co. Kg Company Detail
    Table 138. Weinmann Emergency Medical Technology Gmbh+co. Kg Business Overview
    Table 139. Weinmann Emergency Medical Technology Gmbh+co. Kg Acute Respiratory Distress Syndrome (ARDS) TreatmentProduct
    Table 140. Weinmann Emergency Medical Technology Gmbh+co. Kg Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022) & (US$ Million)
    Table 141. Weinmann Emergency Medical Technology Gmbh+co. Kg Recent Development
    Table 142. Research Programs/Design for This Report
    Table 143. Key Data Information from Secondary Sources
    Table 144. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Oral Features
    Figure 3. Intravenous Injection Features
    Figure 4. Intramuscular Injection Features
    Figure 5. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Application in 2021 & 2028
    Figure 6. Hospital Pharmacy Case Studies
    Figure 7. Retail Pharmacy Case Studies
    Figure 8. Online Pharmacy Case Studies
    Figure 9. Acute Respiratory Distress Syndrome (ARDS) Treatment Report Years Considered
    Figure 10. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Region: 2021 VS 2028
    Figure 13. Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Players in 2021
    Figure 14. Global Top Acute Respiratory Distress Syndrome (ARDS) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Respiratory Distress Syndrome (ARDS) Treatment as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Acute Respiratory Distress Syndrome (ARDS) Treatment Revenue in 2021
    Figure 16. North America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Country (2017-2028)
    Figure 18. United States Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Country (2017-2028)
    Figure 22. Germany Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Region (2017-2028)
    Figure 30. China Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Country (2017-2028)
    Figure 38. Mexico Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Share by Country (2017-2028)
    Figure 42. Turkey Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Acute Respiratory Distress Syndrome (ARDS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Gilead Sciences Inc. Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 45. Terumo Corporation Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 46. Getinge Ab Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 47. Livanova Plc Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 48. Medtronic Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 49. Alung Technologies, Inc. Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 50. Armstrong Medical Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 51. Besmed Health Business Corp. Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 52. Dragerwerk Ag & Co. Kgaa Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 53. Eurosets Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 54. F. Hoffmann-la Roche Ltd. Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 55. Fisher & Paykel Healthcare Limited Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 56. Fresenius Se & Co. Kgaa Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 57. Hamilton Medical Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 58. Nice Neotech Medical Systems Pvt.ltd. Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 59. Nipro Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 60. Pfizer Inc. Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 61. Resmed Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 62. Smiths Medical Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 63. Weinmann Emergency Medical Technology Gmbh+co. Kg Revenue Growth Rate in Acute Respiratory Distress Syndrome (ARDS) Treatment Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Gilead Sciences Inc.
Terumo Corporation
Getinge Ab
Livanova Plc
Medtronic
Alung Technologies, Inc.
Armstrong Medical
Besmed Health Business Corp.
Dragerwerk Ag & Co. Kgaa
Eurosets
F. Hoffmann-la Roche Ltd.
Fisher & Paykel Healthcare Limited
Fresenius Se & Co. Kgaa
Hamilton Medical
Nice Neotech Medical Systems Pvt.ltd.
Nipro
Pfizer Inc.
Resmed
Smiths Medical
Weinmann Emergency Medical Technology Gmbh+co. Kg
Frequently Asked Questions
Acute Respiratory Distress Syndrome (ARDS) Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acute Respiratory Distress Syndrome (ARDS) Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acute Respiratory Distress Syndrome (ARDS) Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports